Published in Arch Intern Med on August 24, 1995
Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis (2008) 4.46
The incidence of herpes zoster in a United States administrative database. J Gen Intern Med (2005) 3.31
Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis (2009) 2.74
Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA (2012) 2.51
T cell subset-specific susceptibility to aging. Clin Immunol (2008) 2.42
Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis (2008) 2.25
A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity (2011) 2.15
Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis (2009) 2.13
Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin (2008) 1.99
Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol (2010) 1.96
Risk of stroke following herpes zoster: a self-controlled case-series study. Clin Infect Dis (2014) 1.91
Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis (2010) 1.85
Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open (2014) 1.81
Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study. PLoS Med (2013) 1.79
Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc (2011) 1.75
Update on herpes zoster vaccination: a family practitioner's guide. Can Fam Physician (2011) 1.74
Vaccination against Herpes Zoster and Postherpetic Neuralgia. J Infect Dis (2008) 1.70
Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they? Am J Epidemiol (2011) 1.58
The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health (2005) 1.57
Preventing varicella-zoster disease. Clin Microbiol Rev (2005) 1.55
Prognostic value of Hutchinson's sign in acute herpes zoster ophthalmicus. Graefes Arch Clin Exp Ophthalmol (2003) 1.55
Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis (2013) 1.54
Varicella vaccination--a critical review of the evidence. Arch Dis Child (2001) 1.52
Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. Infection (2011) 1.52
Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect (2007) 1.48
Impact of varicella vaccine on varicella-zoster virus dynamics. Clin Microbiol Rev (2010) 1.47
Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster. JAMA (2013) 1.45
Health care utilization and cost burden of herpes zoster in a community population. Mayo Clin Proc (2009) 1.42
Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination. Arthritis Rheumatol (2016) 1.40
Herpes zoster eye complications: rates and trends. Mayo Clin Proc (2013) 1.25
Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Br J Clin Pharmacol (2008) 1.23
The risk and prognosis of cancer after hospitalisation for herpes zoster: a population-based follow-up study. Br J Cancer (2004) 1.13
Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children. J Acquir Immune Defic Syndr (2009) 1.11
Incidence of herpes zoster in patients with altered immune function. Infection (2013) 1.09
TNF-α antagonist use and risk of hospitalization for infection in a national cohort of veterans with rheumatoid arthritis. Medicine (Baltimore) (2011) 1.09
Signal inhibition by the dual-specific phosphatase 4 impairs T cell-dependent B-cell responses with age. Proc Natl Acad Sci U S A (2012) 1.08
CD28 co-signaling in the adaptive immune response. Self Nonself (2010) 1.08
Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiol Rev (2013) 1.06
Chronic medical conditions as risk factors for herpes zoster. Mayo Clin Proc (2012) 1.06
Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany. Eur J Health Econ (2012) 1.05
Clinical diagnosis of herpes zoster in family practice. Ann Fam Med (2007) 1.05
Immune aging and rheumatoid arthritis. Rheum Dis Clin North Am (2010) 1.05
The immune system and the impact of zinc during aging. Immun Ageing (2009) 1.03
Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis (2011) 0.99
Prodromal herpes zoster mimicking odontalgia--a diagnostic challenge. Ethiop J Health Sci (2013) 0.98
Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination. Sci Transl Med (2016) 0.97
Major depressive disorder and immunity to varicella-zoster virus in the elderly. Brain Behav Immun (2011) 0.96
Comparison of the levels of immunogenicity and safety of Zostavax in adults 50 to 59 years old and in adults 60 years old or older. Clin Vaccine Immunol (2009) 0.96
The consistency of shingles and its significance for health monitoring. Eur J Epidemiol (2004) 0.95
Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain). BMC Fam Pract (2010) 0.93
Annual incidence rates of herpes zoster among an immunocompetent population in the United States. BMC Infect Dis (2015) 0.92
Treatment of herpes zoster. Can Fam Physician (2008) 0.92
T-cell co-stimulatory pathways in autoimmunity. Arthritis Res Ther (2008) 0.91
Environmental chemical exposures and risk of herpes zoster. Environ Health Perspect (1999) 0.91
Preventing Chronic Pain following Acute Pain: Risk Factors, Preventive Strategies, and their Efficacy. Eur J Pain Suppl (2011) 0.90
Herpes zoster incidence in a multicenter cohort of solid organ transplant recipients. Transpl Infect Dis (2011) 0.89
Incidence and risk factors of herpes zoster among hiv-positive patients in the german competence network for HIV/AIDS (KompNet): a cohort study analysis. BMC Infect Dis (2013) 0.89
Age-dependent signature of metallothionein expression in primary CD4 T cell responses is due to sustained zinc signaling. Rejuvenation Res (2008) 0.89
Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany. BMC Health Serv Res (2013) 0.89
Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study. Ophthalmology (2012) 0.88
Increased risk of herpes zoster in children with asthma: a population-based case-control study. J Pediatr (2013) 0.88
Herpes zoster vaccine in Korea. Clin Exp Vaccine Res (2013) 0.88
Chickenpox exposure and herpes zoster disease incidence in older adults in the U.S. Public Health Rep (2007) 0.88
Epidemiological Study on the Incidence of Herpes Zoster in Nearby Cheonan. Korean J Pain (2015) 0.87
Real-world treatment of post-herpetic neuralgia with gabapentin or pregabalin. Clin Drug Investig (2013) 0.86
Risk of herpes zoster among diabetics: a matched cohort study in a US insurance claim database before introduction of vaccination, 1997-2006. Infection (2014) 0.85
Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland. Hum Vaccin (2011) 0.85
Clinical and genetic risk factors of herpes zoster in patients with systemic lupus erythematosus. Rheumatol Int (2003) 0.85
Undiagnosed diabetes mellitus in patients with Herpes Zoster. Indian J Dermatol (2008) 0.85
Incidence and risk factors for herpes zoster following heart transplantation. Transpl Infect Dis (2013) 0.84
Seroepidemiologic survey of varicella-zoster virus in korean adults using glycoprotein enzyme immuno assay and fluorescent antibody to membrane antigen test. Ann Dermatol (2011) 0.84
Clinical and molecular aspects of varicella zoster virus infection. Future Neurol (2009) 0.84
Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia. J Intern Med (2011) 0.83
Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa. Int J Infect Dis (2014) 0.83
Varicella zoster vaccines and their implications for development of HSV vaccines. Virology (2013) 0.83
Measuring access to effective care among elderly medicare enrollees in managed and Fee-for-Service care: a retrospective cohort study. BMC Health Serv Res (2001) 0.82
High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2010) 0.82
Increased Incidence of Herpes Zoster and Postherpetic Neuralgia in Adult Patients following Traumatic Brain Injury: A Nationwide Population-Based Study in Taiwan. PLoS One (2015) 0.82
Influence of systemic immune and cytokine responses during the acute phase of zoster on the development of postherpetic neuralgia. J Zhejiang Univ Sci B (2009) 0.82
Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain). Hum Vaccin Immunother (2014) 0.81
The PINE study: rationale and design of a randomised comparison of epidural injection of local anaesthetics and steroids versus care-as-usual to prevent postherpetic neuralgia in the elderly [ISRCTN32866390]. BMC Anesthesiol (2004) 0.81
Active immunization in the United States: developments over the past decade. Clin Microbiol Rev (2001) 0.80
The effect of immediate reading of screening mammograms on medical care utilization and costs after false-positive mammograms. Health Serv Res (2007) 0.79
Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus. Cornea (2012) 0.79
Epidemiology of Herpes Zoster Ophthalmicus: Recurrence and Chronicity. Ophthalmology (2016) 0.78
Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany. Hum Vaccin Immunother (2015) 0.78
The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study. Proc Biol Sci (2015) 0.78
Acupuncture in acute herpes zoster pain therapy (ACUZoster) - design and protocol of a randomised controlled trial. BMC Complement Altern Med (2009) 0.77
Increasing incidence associated with herpes zoster infection in British Columbia, Canada. BMC Infect Dis (2016) 0.77
Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis. Ann Rheum Dis (2016) 0.77
Immunogenicity and safety of ZOSTAVAX(®) approaching expiry potency in individuals aged ≥50 years. Hum Vaccin (2011) 0.77
The Shozu Herpes Zoster (SHEZ) study: rationale, design, and description of a prospective cohort study. J Epidemiol (2012) 0.77
Immunosenescence: the Role of Aging in the Predisposition to Neuro-Infectious Complications Arising from the Treatment of Multiple Sclerosis. Curr Neurol Neurosci Rep (2017) 0.76
Predictors of shingles reports at diagnosis of common variable immunodeficiency and selective immunoglobulin G subclass deficiency in 212 Alabama adults. Infect Dis Rep (2012) 0.76
Acupuncture for postherpetic neuralgia: a systematic review protocol. BMJ Open (2014) 0.76
Virus reactivation: a panoramic view in human infections. Future Virol (2011) 0.76
Longitudinal risk of herpes zoster in patients with non-Hodgkin lymphoma receiving chemotherapy: A nationwide population-based study. Sci Rep (2015) 0.76
The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling. Am J Epidemiol (2016) 0.75
Herpes Zoster and Risk of Cancer in the Elderly U.S. Population. Cancer Epidemiol Biomarkers Prev (2015) 0.75
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 15.85
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med (2001) 14.48
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08
Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol (1994) 9.90
Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med (2000) 9.05
Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med (1991) 8.66
Annual deaths attributable to obesity in the United States. JAMA (1999) 8.62
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med (1996) 8.57
Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med (1997) 8.43
The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health (1997) 8.00
Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med (1995) 7.62
Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA (1998) 7.09
Plasma organochlorine levels and the risk of breast cancer. N Engl J Med (1997) 7.02
Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA (1997) 6.92
The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med (2001) 6.37
Abdominal adiposity and coronary heart disease in women. JAMA (1998) 6.21
Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med (2000) 5.63
Vitamin E consumption and the risk of coronary disease in women. N Engl J Med (1993) 5.39
A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med (2000) 5.17
Birthweight as a risk factor for breast cancer. Lancet (1996) 5.05
Intake of trans fatty acids and risk of coronary heart disease among women. Lancet (1993) 5.00
Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 4.96
Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol (1997) 4.84
Dual effects of weight and weight gain on breast cancer risk. JAMA (1997) 4.81
Dietary fat and fiber in relation to risk of breast cancer. An 8-year follow-up. JAMA (1992) 4.80
Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA (1995) 4.78
Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1998) 4.74
Weight as a risk factor for clinical diabetes in women. Am J Epidemiol (1990) 4.64
A prospective study of passive smoking and coronary heart disease. Circulation (1997) 4.51
A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA (1997) 4.50
Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ (1997) 4.49
Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med (1999) 4.49
Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA (1997) 4.49
Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA (1999) 4.43
A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr (2000) 4.38
Smoking cessation and decreased risk of stroke in women. JAMA (1993) 4.36
Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care (1999) 4.35
Pharmacotherapy for obesity -- do the benefits outweigh the risks? N Engl J Med (1996) 4.32
Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst (1999) 4.27
Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr (2001) 4.26
Alcohol consumption and mortality among women. N Engl J Med (1995) 4.22
Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos Int (2012) 4.09
Using automated medical records for rapid identification of illness syndromes (syndromic surveillance): the example of lower respiratory infection. BMC Public Health (2001) 4.05
Fruit and vegetable intake and risk of cardiovascular disease: the Women's Health Study. Am J Clin Nutr (2000) 3.99
Physical activity and risk of stroke in women. JAMA (2000) 3.95
Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr (1999) 3.91
Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr (1999) 3.89
Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst (1995) 3.88
Contraindicated use of cisapride: impact of food and drug administration regulatory action. JAMA (2000) 3.81
Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol (1997) 3.75
A prospective study of cigarette smoking and risk of cataract in men. JAMA (1992) 3.72
Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev (1995) 3.70
Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study. JAMA (1996) 3.69
The validity of recalled weight among younger women. Int J Obes Relat Metab Disord (1995) 3.68
Physical activity and coronary heart disease in women: is "no pain, no gain" passé? JAMA (2001) 3.65
Dietary patterns and the risk of coronary heart disease in women. Arch Intern Med (2001) 3.59
Body weight, weight change, and risk for hypertension in women. Ann Intern Med (1998) 3.56
Primary prevention of stroke. N Engl J Med (1995) 3.43
The primary prevention of coronary heart disease in women. N Engl J Med (1995) 3.40
Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med (1996) 3.35
Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings? N Engl J Med (1995) 3.29
Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst (1999) 3.22
Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA (1999) 3.21
Prospective study of shift work and risk of coronary heart disease in women. Circulation (1995) 3.18
Body weight and longevity. A reassessment. JAMA (1987) 3.13
A prospective study of risk factors for pulmonary embolism in women. JAMA (1997) 3.12
Fish consumption and risk of sudden cardiac death. JAMA (1998) 3.06
A prospective study of body mass index, weight change, and risk of stroke in women. JAMA (1997) 3.04
Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr (1999) 3.03
Physical activity and risk for cardiovascular events in diabetic women. Ann Intern Med (2001) 3.01
Reducing vancomycin use utilizing a computer guideline: results of a randomized controlled trial. J Am Med Inform Assoc (1998) 2.96
Birth weight and adult hypertension and obesity in women. Circulation (1996) 2.92
Cutaneous disease and drug reactions in HIV infection. N Engl J Med (1993) 2.89
Intramuscular versus oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia. J Pediatr (1994) 2.79
Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med (1990) 2.78
Childhood socioeconomic status and risk of cardiovascular disease in middle aged US women: a prospective study. J Epidemiol Community Health (1995) 2.76
Dietary protein and risk of ischemic heart disease in women. Am J Clin Nutr (1999) 2.73
Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med (2000) 2.68
Physical activity and breast cancer risk in a cohort of young women. J Natl Cancer Inst (1998) 2.67
The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med (2001) 2.67
Body weight and mortality. A 27-year follow-up of middle-aged men. JAMA (1993) 2.65
A model-adjusted space-time scan statistic with an application to syndromic surveillance. Epidemiol Infect (2005) 2.65
Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA (2001) 2.62
A prospective study of weight change and health-related quality of life in women. JAMA (1999) 2.60
Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst (1993) 2.52
Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis (2001) 2.51
Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr (2001) 2.48
Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study. JAMA (1993) 2.45
Inhaled steroids and the risk of hospitalization for asthma. JAMA (1997) 2.45
Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women. Am J Clin Nutr (2001) 2.41
Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke (1999) 2.41
Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics (2001) 2.41
Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol (1994) 2.37
Surgical site infections occurring after hospital discharge. J Infect Dis (1996) 2.35
KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric (2005) 2.32
A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA (1996) 2.27
Smoking cessation in relation to total mortality rates in women. A prospective cohort study. Ann Intern Med (1993) 2.27
Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men. Hypertension (2000) 2.23
Mortality associated with nosocomial urinary-tract infection. N Engl J Med (1982) 2.23
Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. N Engl J Med (1998) 2.21